Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
241 studies found for:    Open Studies | "Thyroid Diseases"
Show Display Options
Rank Status Study
1 Recruiting Scientific Protocol for the Study of Thyroid Cancer and Other Thyroid Disease in Belarus Following the Chernobyl Accident
Conditions: Thyroid Cancer;   Thyroid Disease
Intervention:
2 Recruiting NeoThyr - the Role of Mitochondria-dysfunction in Newborns of Mothers With Autoimmune Thyroid Disease
Conditions: Subclinical Hypothyroidism;   Autoimmune Thyroid Disease;   Alteration of Mitochondrial Membrane
Intervention:
3 Recruiting Dabrafenib With or Without Trametinib in Treating Patients With Recurrent Thyroid Cancer
Conditions: Follicular Thyroid Cancer;   Insular Thyroid Cancer;   Papillary Thyroid Cancer;   Recurrent Thyroid Cancer
Interventions: Drug: dabrafenib;   Drug: trametinib;   Other: Correlative Studies
4 Recruiting Thyroid Disease Serum Repository
Condition: Thyroid Disease
Intervention:
5 Recruiting Pre-Operative Nodal Staging of Thyroid Cancer Using Ultra-Small Superparamagnetic Iron Oxide Magnetic Resonance Imaging (USPIO MRI): Preliminary Study
Conditions: Papillary Carcinoma of Thyroid Metastatic to Regional Lymph Node;   Metastatic Medullary Thyroid Cancer;   Follicular Thyroid Cancer Lymph Node Metastasis
Interventions: Drug: Ferumoxytol;   Device: lymphotrophic superparamagnetic nanoparticles (LSN MRI).
6 Recruiting Clinical Validation of a Molecular Signature to Detect Cancer in Thyroid Nodules With Indeterminate Cytology
Conditions: Thyroid Nodule;   Thyroid Cancer
Intervention: Procedure: FNA biopsy for thyroid nodule(s)
7 Recruiting Studies on Tumors of the Thyroid
Conditions: Neoplasm Metastasis;   Thyroid Neoplasm;   Thyroid Nodule
Intervention:
8 Not yet recruiting FDG-PET/CT in Evaluation of Cytological Indeterminate Thyroid Nodules to Prevent Unnecessary Surgery (EfFECTS)
Conditions: Thyroid Nodule;   Thyroid Neoplasms
Interventions: Procedure: Diagnostic Thyroid Surgery;   Device: Ultrasound of the head and neck;   Radiation: FDG-PET/CT
9 Not yet recruiting A Phase II Study of MLN0128 in Metastatic Anaplastic Thyroid Cancer
Conditions: Anaplastic Thyroid Cancer;   Thyroid Cancer
Intervention: Drug: MLN0128
10 Recruiting Sentinel Lymphnode in Patients With Papillary Thyroid Carcinoma and in Patients With Suspected Thyroid Neoplasia
Conditions: Thyroid Neoplasms;   Thyroid Cancer
Intervention: Procedure: Histological investigation of the SN
11 Recruiting Radiofrequency Ablation in Thyroid Nodules
Condition: Thyroid Nodules
Intervention: Procedure: Radiofrequency ablation of the thyroid nodule
12 Recruiting Nintedanib(BIBF1120) in Thyroid Cancer
Conditions: Medullary Thyroid Cancer (MTC);   Differentiated Thyroid Cancer (DTC)
Interventions: Drug: Nintedanib;   Drug: Placebo
13 Recruiting Dabrafenib and Lapatinib Ditosylate in Treating Patients With Refractory Thyroid Cancer That Cannot Be Removed by Surgery
Conditions: Anaplastic Thyroid Cancer;   Insular Thyroid Cancer;   Recurrent Thyroid Cancer;   Stage IVA Follicular Thyroid Cancer;   Stage IVA Papillary Thyroid Cancer;   Stage IVB Follicular Thyroid Cancer;   Stage IVB Papillary Thyroid Cancer;   Stage IVC Follicular Thyroid Cancer;   Stage IVC Papillary Thyroid Cancer;   Thyroid Gland Medullary Carcinoma;   Thyroid Gland Nonmedullary Carcinoma
Interventions: Drug: lapatinib ditosylate;   Drug: dabrafenib;   Other: pharmacological study;   Other: laboratory biomarker analysis
14 Recruiting Cabozantinib-S-Malate in Treating Patients With Refractory Thyroid Cancer
Conditions: Insular Thyroid Cancer;   Recurrent Thyroid Cancer;   Stage I Follicular Thyroid Cancer;   Stage I Papillary Thyroid Cancer;   Stage II Follicular Thyroid Cancer;   Stage II Papillary Thyroid Cancer;   Stage III Follicular Thyroid Cancer;   Stage III Papillary Thyroid Cancer;   Stage IVA Follicular Thyroid Cancer;   Stage IVA Papillary Thyroid Cancer;   Stage IVB Follicular Thyroid Cancer;   Stage IVB Papillary Thyroid Cancer;   Stage IVC Follicular Thyroid Cancer;   Stage IVC Papillary Thyroid Cancer
Interventions: Drug: cabozantinib-s-malate;   Other: laboratory biomarker analysis
15 Recruiting Cediranib Maleate With or Without Lenalidomide in Treating Patients With Thyroid Cancer
Conditions: Recurrent Thyroid Cancer;   Stage I Follicular Thyroid Cancer;   Stage I Papillary Thyroid Cancer;   Stage II Follicular Thyroid Cancer;   Stage II Papillary Thyroid Cancer;   Stage III Follicular Thyroid Cancer;   Stage III Papillary Thyroid Cancer;   Stage IVA Follicular Thyroid Cancer;   Stage IVA Papillary Thyroid Cancer;   Stage IVB Follicular Thyroid Cancer;   Stage IVB Papillary Thyroid Cancer;   Stage IVC Follicular Thyroid Cancer;   Stage IVC Papillary Thyroid Cancer
Interventions: Drug: cediranib maleate;   Drug: lenalidomide;   Other: laboratory biomarker analysis
16 Not yet recruiting PET Evaluation of Recurrent Differentiated Thyroid Cancer
Conditions: Thyroid Neoplasms;   Differentiated Thyroid Cancer
Intervention:
17 Recruiting Study of Thyrotropin-Releasing Hormone in Normal Volunteers and in Patients With Thyroid or Pituitary Abnormalities
Conditions: Healthy;   Pituitary Disease;   Thyroid Disease
Intervention: Drug: TRH (Thyrotropin Releasing Hormone)
18 Recruiting A Phase II Trial of Cabozantinib for the Treatment of Radioiodine (RAI)-Refractory Differentiated Thyroid Carcinoma (DTC) in the First-line Setting
Conditions: Differentiated Thyroid Cancer (DTC);   Poorly Differentiated Thyroid Cancer
Intervention: Drug: Cabozantinib
19 Recruiting Trametinib in Increasing Tumoral Iodine Incorporation in Patients With Recurrent or Metastatic Thyroid Cancer
Conditions: Recurrent Thyroid Cancer;   Stage IVA Follicular Thyroid Cancer;   Stage IVA Papillary Thyroid Cancer;   Stage IVB Follicular Thyroid Cancer;   Stage IVB Papillary Thyroid Cancer;   Stage IVC Follicular Thyroid Cancer;   Stage IVC Papillary Thyroid Cancer
Interventions: Radiation: iodine I 124;   Procedure: positron emission tomography;   Procedure: computed tomography;   Drug: trametinib;   Radiation: iodine I 131;   Other: laboratory biomarker analysis;   Other: pharmacological study
20 Recruiting Diagnostic Value of Molecular Cytological Analysis (CMA) and Shear Wave Elastography ShearWave (SWE) in Patients With a Thyroid Nodule With Indeterminate Cytology: Feasibility Study
Conditions: Thyroid Node;   Indeterminate Cytology;   Surgery Indication
Intervention: Procedure: aspiration in thyroid node for Molecular Cytogenetic Analysis.

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years